HIGHLIGHTS
- who: Lucillia Bezu and collaborators from the Université de Paris, Sorbonne, INSERM, Centre de Recherche des Cordeliers, Paris, France Department of Women's and Children's Health, Karolinska Institute, Karolinska University Hospital have published the research: Immunological Effects of Epigenetic Modifiers, in the Journal: Cancers 2019, 11, 1911 of /2019/
- what: In this review, the authors provide an overview on epigenetic modifiers used as stand-alone agents or in In this study, a significant decrease of serum cytokines levels of T-cell PD-1 expression after the use of panobinostat was reported, further underlining the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.